Walleye Capital
BIO icon

Walleye Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Walleye Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,500
Closed -$410K – 5306
2024
Q2 		$410K Buy
+1,500
New +$436K ﹤0.01% 3677
2024
Q1 		– Sell
-1,281
Closed -$421K – 5440
2023
Q4 		$414K Buy
+1,281
New +$402K 0.01% 3098
2023
Q1 		– Sell
-3,330
Closed -$1.4M – 3997
2022
Q4 		$1.4M Sell
3,330
-7,564
-69% -$3.05M 0.03% 780
2022
Q3 		$4.54M Buy
10,894
+8,233
+309% +$4.1M 0.1% 249
2022
Q2 		$1.32M Sell
2,661
-5,983
-69% -$3.12M 0.04% 513
2022
Q1 		$4.87M Buy
8,644
+7,600
+728% +$4.58M 0.14% 168
2021
Q4 		$789K Buy
1,044
+280
+37% +$210K 0.03% 722
2021
Q3 		$570 Buy
+764
New +$572K 0.02% 730
2019
Q4 		– Sell
-10
Closed -$3.52K – 1842
2019
Q3 		$3K Sell
10
-20
-67% -$6.52K ﹤0.01% 1821
2019
Q2 		$9K Buy
+30
New +$8.98K 0.01% 1595

Other funds holding BIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $18.8B AUM 17.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return